- Home
- NCEL vs QNRX Comparison
NCEL vs QNRX Comparison
Compare NCEL & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.75
HOLD
Current Price
$21.15
Company Overview
Basic Information| Metric | NCEL | QNRX |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3M | 17.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NCEL | QNRX |
|---|---|---|
| Price | $3.75 | $21.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 147.3K | ★ 1.0M |
| Earning Date | 12-01-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.06 | $5.01 |
| 52 Week High | $7.64 | $48.30 |
Technical Indicators
Market Signals| Indicator | NCEL | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 69.30 |
| Support Level | N/A | $16.50 |
| Resistance Level | N/A | $23.50 |
| Average True Range (ATR) | 0.00 | 2.85 |
| MACD | 0.00 | 0.78 |
| Stochastic Oscillator | 0.00 | 88.09 |
Price Performance
Historical Comparison NCEL
QNRX
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.